Holen Sie sich die Stockscreener-App
6.57
1.70%
0.11
Handel nachbörslich:
6.57
Autonomix Medical Inc Aktie (AMIX) Neueste Nachrichten
Autonomix Medical, Inc. 8-K Filing: NASDAQ Compliance Update and Company Details (July 2026) - Minichart
Autonomix Medical Regains Nasdaq Compliance, Preserving Listing Status - TipRanks
Autonomix Medical regains Nasdaq compliance after 10-day $1.00 bid-price streak - TradingView
Autonomix Medical (NASDAQ: AMIX) restores Nasdaq minimum bid price compliance - Stock Titan
AMIXAutonomix Medical Inc Options - Finviz
Autonomix Medical Inc. (AMIX) Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Company Advances R&DConsensus Forecast Report - dars.gov.et
Enterprise value to EBIT forward of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
Price to book forward of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
Autonomix Medical Enacts 1-for-21 Reverse Stock Split - TipRanks
Autonomix Medical (AMIX) consolidates shares in 1-for-21 reverse stock split - Stock Titan
Autonomix Medical Inc (AMIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Autonomix Medical Announces Standalone Neural Sensing Platform with Evidence of Real-Time Renal Nerve Activity - marketscreener.com
Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change - GlobeNewswire
Autonomix sees real-time renal nerve activity changes in preclinical tests - Stock Titan
AMIX Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Surprise Despite Stock DeclineAnalyst Earnings Estimate - dars.gov.et
Autonomix Medical announces 1-for-21 reverse stock split - MSN
AUTONOMIX ANNOUNCES REVERSE STOCK SPLIT - Moomoo
Autonomix Medical announces 1-for-21 reverse stock split By Investing.com - Investing.com Australia
Autonomix Announces Reverse Stock Split - GlobeNewswire
Autonomix Medical Inc (AMIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Autonomix Medical Inc (AMIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Autonomix Medical Inc (AMIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Autonomix Medical Inc (AMIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Autonomix’s shares will be cut 21-for-1 on June 24 - Stock Titan
Autonomix Medical Inc (AMIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Autonomix Medical Inc (AMIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Autonomix Medical Inc (AMIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Autonomix Medical Inc (AMIX) Institutional Confidence - TradingKey
[10-K/A] Autonomix Medical, Inc. Amends Annual Report - Stock Titan
Autonomix Medical (AMIX) Shows Signs of Recovery After Recent DeclineIV Expansion Alert - dars.gov.et
AMIX Q1 2026 Earnings: Narrower-than-expected loss fails to lift sharesEarnings Growth Analysis - newsline.com
AMIX Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineHealthcare Earnings Report - newsline.com
Autonomix Medical, Inc. Financial Disclosures & SEC Filings - TradingView
AMIX Q1 2026 Earnings: Narrower-than-Expected Loss Driven by Disciplined Cost ManagementQuarterly Profit Report - newsline.com
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology - The Globe and Mail
Autonomix Medical, Inc. (AMIX) Upgraded to Strong Buy: Here's Why - MSN
Autonomix Medical (AMIX) Faces Continued Pressure Near $0.40 Support LevelDelta Hedging - newsline.com
Autonomix Medical executive discusses cancer pain treatment data By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. (AMIX) Latest Stock News & Headlines - Yahoo Finance
Autonomix Medical executive discusses cancer pain treatment data - Investing.com
Autonomix Medical Highlights Advances in Visceral Cancer Pain Treatment and Pancreatic Cancer Research in Investor Segment - Quiver Quantitative
Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine - GlobeNewswire
Maxim Group Maintains Autonomix Medical(AMIX.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Autonomix Medical (AMIX) Declines 5.78% as Stock Tests Key Support at $0.37Break of Structure - dars.gov.et
Autonomix Medical Inc. (AMIX) Q1 2026 Earnings: EPS Surprise Delivers Narrower Loss, but Revenue Void Weighs on SharesRevenue Recognition Risk - newsline.com
Autonomix Medical, Inc.: Advancing Precision Neuro-Ablation for Pancreatic Cancer Pain with Innovative Sensing Technology and De Novo FDA Pathway 39 - Minichart
Autonomix Medical FY 2026: Revenue $0 Net loss $16.7M, EPS $(2.32) — 10-K Summary - TradingView
Autonomix Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Autonomix Medical (NASDAQ: AMIX) outlines novel nerve device plans amid going concern risk - Stock Titan
Autonomix Medical, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Autonomix Medical (AMIX) Holds Steady Near Support as Traders Eye Resistance BreakoutLate Stage Breakouts - The Legal Advocate
Autonomix Medical Inc. (AMIX) Edges Higher as Key Support Level HoldsSector Leader Stocks - Newser
Autonomix (AMIX) Jumps +8.71% on Strong Momentum 2026-05-20Ichimoku Kumo Twist - Newser
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation - marketscreener.com
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):